Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 8
2003 15
2004 12
2005 20
2006 28
2007 24
2008 26
2009 34
2010 33
2011 41
2012 46
2013 48
2014 64
2015 72
2016 87
2017 80
2018 75
2019 99
2020 111
2021 137
2022 133
2023 117
2024 48

Text availability

Article attribute

Article type

Publication date

PubMed for id: 232369

1,170 results

Results by year

Filters applied: . Clear all
Page 1
Human leukocyte antigen (HLA) class I expression on Hodgkin-Reed-Sternberg cells is an EBV-independent major determinant of microenvironment composition in classic Hodgkin lymphoma.
Müller-Meinhard B, Seifert N, Grund J, Reinke S, Yalcin F, Kaul H, Borchmann S, von Tresckow B, Borchmann P, Plütschow A, Richter J, Engert A, Altenbuchinger M, Bröckelmann PJ, Klapper W. Müller-Meinhard B, et al. Hemasphere. 2024 Jun 3;8(6):e84. doi: 10.1002/hem3.84. eCollection 2024 Jun. Hemasphere. 2024. PMID: 38836098 Free PMC article.
The biology of classical Hodgkin lymphoma.
Kosydar S, Ansell SM. Kosydar S, et al. Semin Hematol. 2024 May 8:S0037-1963(24)00059-3. doi: 10.1053/j.seminhematol.2024.05.001. Online ahead of print. Semin Hematol. 2024. PMID: 38824068
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Ruggeri E, Frezzato F, Mouawad N, Pizzi M, Scarmozzino F, Capasso G, Trimarco V, Quotti Tubi L, Cellini A, Cavarretta CA, Ruocco V, Serafin A, Angotzi F, Danesin N, Manni S, Facco M, Piazza F, Trentin L, Visentin A. Ruggeri E, et al. Front Immunol. 2024 May 14;15:1393485. doi: 10.3389/fimmu.2024.1393485. eCollection 2024. Front Immunol. 2024. PMID: 38807597 Free PMC article.
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.
Drechsel KCE, Broer SL, Stoutjesdijk FS, van Dulmen-den Broeder E, Beishuizen A, Wallace WH, Körholz D, Mauz-Körholz C, Hasenclever D, Cepelova M, Uyttebroeck A, Ronceray L, Twisk JWR, Kaspers GJL, Veening MA. Drechsel KCE, et al. Hum Reprod. 2024 May 24:deae112. doi: 10.1093/humrep/deae112. Online ahead of print. Hum Reprod. 2024. PMID: 38794915
1,170 results